Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
about
Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporterDrug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.Curaxins: a new family of non-genotoxic multitargeted anticancer agents.Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.Small-molecule xenomycins inhibit all stages of the Plasmodium life cycleRecent progress in targeting cancer.NCI's provocative questions on cancer: some answers to ignite discussion.Engagement of Components of DNA-Break Repair Complex and NFκB in Hsp70A1A Transcription Upregulation by Heat Shock.A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESSImplication of heat shock factors in tumorigenesis: therapeutical potential.Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1.Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.Emergence and natural selection of drug-resistant prions.Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.Acridine and acridinones: old and new structures with antimalarial activity.Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.Targeting HSF1 sensitizes cancer cells to HSP90 inhibition.Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy.Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib.The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.Proteotoxic stress targeted therapy (PSTT).Heat shock proteins and cancer therapy: the trail grows hotter!Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.Inhibition of Kir4.1 potassium channels by quinacrine.Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition.
P2860
Q28480949-29068DC0-AFBD-4BE8-BA10-EF6881D7D3E9Q30409637-FB8A1888-08C4-4C1C-AB79-D4A1803F23D6Q33652585-DD541DF8-2942-4C89-827C-6DC6B62C4442Q34061949-9C426499-B686-470B-926F-2B59B2638330Q34957154-978CA78B-5960-4799-8C9C-77099E700A44Q35013756-76C70B13-F8EB-470F-9F76-E6ACDA21F102Q35076935-9026F7AD-EF0F-4BD9-8DF0-60C2CB0AB102Q35740782-9B056AE5-37C2-49A8-80BA-896E64555C4EQ35764401-401DB9B8-3B73-48A3-952A-37457EC48F79Q36252549-EA1A50C2-E7E4-400C-9D05-3A48A27D8860Q36419222-93847121-81F3-43B9-8D65-06CECE0E05B2Q37129864-F4348C22-2680-409A-B18E-08D7C2FCD8A7Q37694619-E8599999-65EB-4E83-8B62-820F4C4B7378Q37702210-24AE9989-6285-4641-91A3-749937193AC0Q37737577-23A42DE5-B9B3-4182-9D11-271B200C1497Q37882459-E0563CBF-2A81-46A7-9504-0330B84855BBQ37889659-C2D102DB-46D8-449E-84F7-CB0ADC17CF2FQ38744639-89E6CFEF-A8BE-487A-ACD4-5EBAEE5497ACQ39161041-E66E420C-DDA4-4C68-B744-87D533FFA64DQ39505036-88D23C0F-3FD6-44F6-BF99-FC87AB81EA3CQ39547659-3E830219-F0E0-4F2F-9C8A-BCD2821F66DDQ39569161-E5900137-72AC-4DC2-9404-DBDCB3DAEA5AQ42082409-9E1FCDF4-D75D-4585-AA1C-7B9BB74593E5Q43042043-48801BD1-97FD-4776-8813-8016549256BDQ43042078-5C62495D-FA54-46D7-BB2E-FA2CB44D0EDDQ43376660-C7A82E83-7776-419E-B537-37C9DD2D4AC4Q45054509-EAA8318B-A2E4-4EDF-9591-717A8993C226Q55110970-6C10A3E2-8848-4DCB-BB4E-2CA109D13B26
P2860
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@ast
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@en
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@nl
type
label
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@ast
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@en
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@nl
prefLabel
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@ast
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@en
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@nl
P2093
P2860
P356
P1433
P1476
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.
@en
P2093
Alexander V Gasparian
Alexandru Almasan
Amiya K Banerjee
Andrei P Komarov
Andrei V Gudkov
Anton V Gorbachev
Katerina V Gurova
Lubov Neznanova
Nickolay Neznanov
Robert L Fairchild
P2860
P304
P356
10.4161/CC.8.23.10179
P577
2009-12-25T00:00:00Z